Skip to content

Giloy Gomutra Capsule, Asthi churna aur Kamdhenu Asava ka vaishvik mahamari Covid-19 par logo ka anubhav aur Chikitsakiya prabhava ka Ankalan

Real world experience about efficacy and safety of Giloy Gomutra (Cow Urine), Asthi Churna and Kamdhenu Asava in the management of COVID-19 in Indian setting. (REAL Giloy Gomutra, Asthi Churna and Kamdhenu Asava Product)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027083
Enrollment
100
Registered
2020-08-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: 1)Giloy Gaumutra Capsules 2)Asthi Churna 3)Kamdhenu Aasava  : All the three drugs were given to all patients , it will be single experimental group. This Ayurvedic treatment given for

Sponsors

Bansi Gir Gaushala
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Treating physician had to agree to provide information regarding the Patients who have been diagnosed with Covid-19 with mild and moderate symptoms.

Exclusion criteria

Exclusion criteria: Patient having severe symptoms will not be included in the study Any condition that according to the discretion of the investigator indicate that the patient is not suitable for inclusion in the study

Design outcomes

Primary

MeasureTime frame
Covid-19 Negative Test ConfirmationTimepoint: Covid-19 Negative Test Confirmation after recovery around 1 or 2 weeks.

Secondary

MeasureTime frame
All the symptoms will be evaluated for the recovery.Timepoint: All the symptoms will be measured on first day, 7th day and at 15 day of the treatment.

Countries

India

Contacts

Public ContactDr Dineshchandra H Pandya

Neuropanch Ayurveda Hospital and Research Organization

urvipandya18@gmail.com9638300839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026